Mid-Career Investigator Award for Kenneth G. Saag

肯尼思·G·萨格 (Kenneth G. Saag) 职业生涯中期研究员奖

• 批准号: 6906153
• 负责人: Kenneth G Saag
• 金额: $ 13.64万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-06-01 至 2010-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6906153
• 关键词: arthritis; arthritis therapy; behavioral /social science research tag; clinical research; drug adverse effect; glucocorticoids; health care personnel education; health care policy; health care quality; mentoring /mentor; musculoskeletal disorder; nonsteroidal antiinflammatory agent; osteoporosis; outcomes research; patient care management; patient oriented research; physicians; statistics /biometry; training

DESCRIPTION (provided by applicant): For the past 12 years Dr. Saag has been devoting the majority of his career efforts to patient-oriented research in the pharmacoepidemiology of the rheumatic diseases. In addition to competing successfully for peer reviewed grants, including a recent renewal of his $3.2 million AHRQ supported Center for Education and Research on Therapeutics (CERTs) of musculoskeletal disorders, Dr. Saag has published or has in press 50 original reports. Since joining the UAB faculty in 1998, Dr. Saag has been a primary or secondary mentor for rheumatology fellows (2), international fellows (3), and junior faculty members (5), several of whom have already received career development awards. As a clinical investigator, Dr. Saag balances research with patient care and teaching responsibilities. Receipt of a K24 grant would assure his protected time at 50% or greater effort and relieve future clinical and administrative responsibilities. It will increase his time for mentoring and he will add additional trainees and assume new mentoring responsibilities. It is anticipated that one or two new trainees will be recruited into Dr. Saag's research program each year. He will lead a new Arthritis Outcomes and Epidemiology Seminar Series and expand his mentoring role in other areas such as the VA Quality Scholars Program. Following existing UAB models, a program for formal mentoring feedback will be established to guide and refine his mentoring activities. UAB has extensive infrastructure including several T32 training grants, a K30, and numerous pre-existing programs that will facilitate Dr. Saag's training of patient oriented researchers. Thus, UAB and its Schools, Departments, Divisions, and Interdisciplinary Centers provide an outstanding environment for the development of junior investigators in patient-oriented research. Based on institutional commitment and resources and Dr. Saag's successful past record in research and mentoring, the K24 will greatly enhance his ability to expand his research program and to help develop the next generation of patient-oriented clinical investigators.

描述（由申请人提供）： 在过去的12年中，Saag博士一直致力于他的职业生涯大部分努力，以患者为导向的风湿性疾病药物学研究。除了成功竞争同行审查的补助金（包括最近续签其320万美元的AHRQ支持肌肉骨骼疾病的教育与研究中心（CERTS））外，Saag博士还发表或已发表了50种原始报告。自1998年加入UAB教职员工以来，Saag博士一直是风湿病研究员（2），国际研究员（3）和初级教职员工（5）的主要或次要导师（5），其中一些已经获得了职业发展奖。作为临床研究者，Saag博士将研究与患者护理和教学责任保持平衡。收到K24赠款将以50％或更高的努力确保其受保护的时间，并减轻未来的临床和行政责任。这将增加他的指导时间，他将增加其他学员，并承担新的指导责任。预计每年将招募一两个新学员参加Saag博士的研究计划。他将领导新的关节炎结果和流行病学研讨会系列，并扩大他在其他领域（例如VA质量学者计划）中的指导作用。遵循现有的UAB模型，将制定一个正式指导反馈的计划，以指导和完善他的指导活动。 UAB拥有广泛的基础设施，包括几项T32培训补助金，A K30以及许多先前存在的计划，这些计划将促进Saag博士对以患者为导向的研究人员进行培训。因此，UAB及其学校，部门，部门和跨学科中心为开发以患者为导向的研究提供了一个杰出的环境。基于机构的承诺和资源以及Saag博士在研究和指导方面的成功记录，K24将大大增强他扩大研究计划的能力，并帮助发展下一代以患者为导向的临床研究者。